Implementing Monitoring for Opioid-Induced Respiratory Depression in Medical-Surgical and Other General Care Units
November 22, 2016 | Evaluations & Guidance
Patients receiving parenteral and neuraxial opioids are at risk of depressed respiration—a condition that can quickly lead to anoxic brain injury or death if not detected. As a result, several organizations now recommend that these patients be continuously monitored for respiratory depression.
This recommendation presents some significant challenges for healthcare providers. Questions to be addressed include:
Which monitoring technology should be used?
How does a facility budget for acquiring and operating monitors?